A dedicated onconephrology service at Brigham and Women’s Hospital has improved kidney outcomes in patients treated for ...

UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation’s largest health insurer suspended its ...

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm ...

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a ...

With a neutral sentiment as of May 8, 2025, according to Moneycontrol analysis, GlaxoSmithKline Pharmaceuticals demonstrates ...

In recent years, the U.K.-listed pharma giant has called increasingly on U.S. law firms for its transactional work.

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Net Sales at Rs 966.08 crore in March 2025 up 6.06% from Rs. 910.87 crore in March 2024. Quarterly Net Profit at Rs. 260.14 crore in March 2025 up 34.73% from Rs. 193.08 crore in March 2024. EBITDA ...

The head of UnitedHealth Group is stepping down, ending a rocky four years marked by rising medical costs, a major ...